Associate Professor, Radiation Oncology, Director, Photodymanic Therapy Program Perelman School of Medicine
Radiation Oncology
Dr. Keith A. Cengel, MD
|
|
Give Review
Keith Cengel works in the field of Radiation Oncology. He graduated from University of Illinois College of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Keith A. Cengel has written publications. He has 63 publications published with PubMed. The lastest paper is: 'Phosphatidylinositol 3''-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF MALIGNANT MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY.
- Toxicities and early outcomes in a phase 1 trial of photodynamic therapy for premalignant and early stage head and neck tumors.
- Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?
- Photoactive fluoropolymer surfaces that release sensitizer drug molecules.
- Photodynamic therapy for lung cancer and malignant pleural mesothelioma.
- Comparative analysis of colorimetric staining in skin using open-source software.
- PTH1-34 Blocks Radiation-Induced Osteoblast Apoptosis by Enhancing DNA Repair through Canonical Wnt Pathway.
- In Regard to Tang et al.
- Acute Hematological Effects in Mice Exposed to the Expected Doses, Dose-rates, and Energies of Solar Particle Event-like Proton Radiation.
- PTH1-34 alleviates radiotherapy-induced local bone loss by improving osteoblast and osteocyte survival.
- Pencil beam scanning dosimetry for large animal irradiation.
- Perineural spread of malignant mesothelioma with spinal intramedullary involvement.
- Monte Carlo modeling in CT-based geometries: dosimetry for biological modeling experiments with particle beam radiation.
- Acute effects of solar particle event radiation.
- Relative biological effectiveness of simulated solar particle event proton radiation to induce acute hematological change in the porcine model.
- Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation.
- Acute Hematological Effects of Solar Particle Event Proton Radiation in the Porcine Model.
- PTH prevents the adverse effects of focal radiation on bone architecture in young rats.
- Protective effect of transparent film dressing on proton therapy induced skin reactions.
- Adapting preclinical concepts for use in clinical trials of serosal and interstitial photodynamic therapy.
- Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.
- Ionizing radiation selectively reduces skin regulatory T cells and alters immune function.
- Radiation mitigating properties of the lignan component in flaxseed.
- Photodynamic therapy for the treatment of non-small cell lung cancer.
- The biobehavioral and neuroimmune impact of low-dose ionizing radiation.
- Acute biological effects of simulating the whole-body radiation dose distribution from a solar particle event using a porcine model.
- Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice.
- Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma.
- Photodynamic therapy of cancer: an update.
- Transoral robotic photodynamic therapy for the oropharynx.
- Interference with the Jaffé method for creatinine following 5-aminolevulinic acid administration.
- Using electron beam radiation to simulate the dose distribution for whole body solar particle event proton exposure.
- Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesothelioma.
- Pleural malignancies.
- Effects of anti-EGFR antibody cetuximab on androgen-independent prostate cancer cells.
- Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice.
- Postsurgical atypical F-18 fluorodeoxyglucose positron emission tomography uptake.
- Hemithoracic radiotherapy after extrapleural pneumonectomy for malignant pleural mesothelioma: a dosimetric comparison of two well-described techniques.
- Tumor-Stroma interactions in pancreatic cancer: Will this SPARC prove a raging fire?
- Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury.
- Anti-inflammatory therapy for pancreatic cancer: a sorely needed advance in therapeutics.
- Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigen.
- Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity.
- Clinical target promiscuity: lessons from ras molecular trials.
- Intraperitoneal photodynamic therapy.
- Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.
- Combination therapy with gemcitabine and 5-Fluorouracil: unblocking the pathways to survivin?
- Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse.
- Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines.
- The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
- Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.
- C225 and PDT combination therapy for ovarian cancer: the play's the thing.
- Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
- Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
- Targeting Sonic Hedgehog: a new way to mow down pancreatic cancer?
- Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
- CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kin...
- JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation.
- Insulin activates caspase-3 by a phosphatidylinositol 3'-kinase-dependent pathway.
- Phosphatidylinositol 3''-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
- Phosphatidylinositol 3'-kinase is associated with a serine kinase that is activated by okadaic acid.
- Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.
Schools
Univ Of Il Coll Of Med
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
University of Illinois College of Medicine
Hospital
-
Philadelphia Veterans Affairs Medical Center -
Hospital of the University of Pennsylvania -
Pennsylvania Hospital -
Penn Presbyterian Medical Center
Drug Facts
| NPI NUMBER | 1013010511 | |
| NPPES Provider LastName | CENGEL | |
| NPPES Provider FirstName | KEITH | |
| NPPES Provider ZIPCode | 191045127 | |
| NPPES Provider State | PA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013010511 |
| Last Name Of The Provider | CENGEL |
| First Name Of The Provider | KEITH |
| View All |
Similar Doctors
|
Dr. Aruna Turaka, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Penny R. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nicholas G. Zaorsky, MD |
|
|
Dr. Mark V. Mishra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan C. Cleary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan T. Whaley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gita Suneja, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Pablo L. Gonzalez Lavagnini, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Surbhi Grover, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric L. Gressen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Curtis Miyamoto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Glassburn, MD
This Doctor is OpenDoctor Recommended.
|